Results 171 to 180 of about 75,798 (257)

Structural Diversification of 14-Membered Macrolides by Chemoenzymatic Synthesis. [PDF]

JACS Au
Curtis BJ, Boesger HA, Schmidt JJ, Adrover-Castellano ML, Momin AN, Glasser CA, Sherman DH.   +6 more
europepmc   +1 more source

Immunomodulation, cytokines and antibiotics [PDF]

, 2010
Croubels, Siska, De Backer, Patrick
core  

Clinical performance of two commercial PCR assays for the detection of macrolide resistance in <i>Mycoplasma pneumoniae</i>. [PDF]

J Clin Microbiol
Hénin N, Silvant A, Gardette M, Balcon C, Guiraud J, Bébéar C, Pereyre S.   +6 more
europepmc   +1 more source

Macrolide [PDF]

, 2020
openaire   +1 more source

Growing Threat of Macrolide-Resistant <i>Mycoplasma pneumoniae</i> Among Children: What We Know and What We Need. [PDF]

J Korean Med Sci
Yun KW.
europepmc   +1 more source

Pharmacokinetics of FK 506: Preclinical and clinical studies [PDF]

, 1990
Cadoff, E, Fung, JJ, Imventarza, O, Iwasaki, K, Jain, A, Krajack, A, Nagase, K, Starzl, TE, Todo, S, Venkataramanan, R, Warty, V   +10 more
core  

Genomic characterization of mobile genetic elements associated with antimicrobial resistance in <i>Streptococcus pneumoniae</i> from Australia. [PDF]

Microb Genom
Sunmonu GT, Coldbeck-Shackley RC, Graham RMA, Leong LE, Ogunniyi AD, Sheppard AE.   +5 more
europepmc   +1 more source

The use of macrolides in the treatment of community-acquired pneumonia: risks and benefits. [PDF]

Breathe (Sheff)
Al-Zergani F, Bastrup Israelsen S, Benfield T, Fally M.   +3 more
europepmc   +1 more source

Factors associated with patient adherence to medical recommendations during a health crisis. [PDF]

PLoS One
Reiner-Benaim A, Amar S.
europepmc   +1 more source

<i>Legionellosis</i>: Global Epidemiology and Current Perspectives on Diagnosis and Treatment. [PDF]

Infect Drug Resist
Ma J, Dong T, Li F, He C, Li B, Liu Z.
europepmc   +1 more source